Mass vaccination has been the main policy to overcome the Covid-19 pandemic. Several vaccines have been approved by the World Health Organization. With growing vaccination, safety concerns and adverse events that need prompt evaluation are also emerging. Herein, we report a case of a healthy woman with longitudinally extensive transverse myelitis after vaccination with the AstraZeneca vaccine. The patient was successfully treated after ruling out all the possible causes.
All Keywords
【저자키워드】 COVID-19, AstraZeneca, transverse myelitis,
【저자키워드】 COVID-19, AstraZeneca, transverse myelitis,